MENU
TNXP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Tonix Pharmaceuticals Holding (TNXP) Ownership - Who owns Tonix Pharmaceuticals Holding?

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering... Show more

Profile

Industry
Pharmaceuticals Other
Address
26 Main Street
Phone
+1 862 799-8599
Employees
103
Web
https://www.tonixpharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
238.08M
P/E Ratio
0.09
Total Cash
131.72M
Projected Growth
N/A
Total Debt
563K
Revenue
10.04M
Risk (Beta)
1.84
Dividend Yield
N/A
Total Cash/Share
17.90
Total Debt/Equity
0.58
Revenue/Share
4.54 USD as % of share price

Fundamentals

TNXP
Capitalization
238M
P/E Ratio
0.09
Risk (Beta)
1.84
Dividend Yield
N/A
Total Cash
132M
Total Cash/Share
17.90
Total Debt
563K
Total Debt/Equity
0.58
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
4.54%
Revenue
10M
ROE
N/A
Book Value
180M
P/B Ratio
1.34
Cash Flow
N/A
Earnings
356.28
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7K
Current Ratio
12.31
Current Revenue Per Employee
29987.65
Dividends Per Share - Security
N/A
EBITDA
-66.23M
Float
N/A
Float - Current
N/A
Gross Income Margin
61.18
Revenue To Assets
-80.39
Shares Held By Institutions
11.3M
Shares Outstanding - Current
7.36M
Total Liabilities
12.5M
Total Volume MTD
N/A
Value
1
Gain YTD
-0.576
View a ticker or compare two or three
TNXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company which engages in developing and manufacturing pharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
26 Main Street
Phone
+1 862 799-8599
Employees
103
Web
https://www.tonixpharma.com